A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer

Overview of attention for article published in Redox Biology, October 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 2,687)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 24 news outlets
blogs: 4 blogs
twitter: 301 X users
facebook: 2 Facebook pages

reddit: 6 Redditors
video: 1 YouTube creator
bluesky: 10 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 26 news stories from 24 outlets.

Perspectives From the Ever-Changing Multidisciplinary Oncology Field

Cancer Network, 31 Mar 2026

Multidisciplinary care is an often-overlooked yet integral aspect of the overarching treatment paradigm.

Perspectives From the Ever-Changing Multidisciplinary Oncology Field

UBM Medica, 31 Mar 2026

Three experts in surgery, radiation, and integrative care disclosed the most salient advances and keen insights in their…

News story from Top Santé on Saturday 29 November 2025

Top Santé, 29 Nov 2025

The Hidden Weapon Against Terminal Cancer

Desert Review, 29 Nov 2025

An Agent Almost No One Knows About Today, I witnessed something remarkable. A patient whose sister is battling pancreatic cancer…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 22 additional news stories.